Abstract
Purpose
To develop paclitaxel-delivering PLGA microspheres entrapped in a gel matrix with sustained drug release properties and implantability advantages for local glioma chemotherapy.
Methods
Paclitaxel-loaded PLGA microspheres were fabricated using electrohydrodynamic atomization and entrapped by electrospray and gelation. The physicochemical characterizations were performed using scanning electron microscopy and differential scanning calorimetry. The influence of various parameters on the disintegration time was investigated. In vitro release of paclitaxel was quantified using high performance liquid chromatography. Cytotoxicity of the formulations was assessed by the quantification of IC50 and caspase-3 activity against C6 glioma cells in vitro. The formulations were tested against a subcutaneous C6 glioma tumour in mice.
Results
Highly monodisperse gel beads containing a uniform microsphere distribution were obtained. Gelation using Ca2+ ions ensured entrapment of microspheres with high loading efficiency. With an increase in the gelation time, gelling bath concentration and decrease in microsphere loading, it was more difficult to disintegrate the beads and release the microspheres. The formulations demonstrated sustained drug release for more than 60 days at a near-constant rate and a low initial burst. Cell culture studies proved the cytotoxicity against C6 glioma and improved performance in comparison to Taxol®. The formulations could reduce subcutaneous tumour volume to a greater extent compared to Taxol® and the control.
Conclusions
Paclitaxel-loaded PLGA microspheres entrapped in an alginate gel matrix could be potential local chemotherapy implants to treat malignant glioma with critical advantages of implantability and sustained drug release with low initial burst.
Similar content being viewed by others
REFERENCES
Petri B, Bootz A, Khalansky A, Hekmatara T, Muller R, Uhl R, et al. Chemotherapy of brain tumor using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. J Control Release. 2007;117:51–58.
Pradilla G, Wang PP, Gabikian P, Li K, Magee CA, Walter KA. Local intracerebral administration of paclitaxel with the Paclimer® delivery system: toxicity study in a canine model. J Neuro-Oncol. 2006;76:131–138.
Limentani SA, Asher A, Heafner M, Kim JW, Fraser R. A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme. J Neuro-Oncol. 2005;72:241–244.
von Eckardstein KL, Patt S, Kratzel C, Kiwit JCW, Reszka R. Local chemotherapy of F98 rat glioblastoma with paclitaxel and carboplatin embedded in liquid crystalline cubic phases. J Neuro-Oncol. 2005;72:209–215.
Brem H. Polymers to treat brain tumors. Biomaterials. 1990;11:699–701.
Tamargo RJ, Myseros JS, Epstein JI, Yang MB, Chasin M, Brem H. Interstitial chemotherapy of the 9 L gliosarcoma: controlled release polymers for drug delivery in the brain. Cancer Res. 1993;53:329–333.
Brem H, Mahaley MS Jr, Vick NA, Black KL, Schold SC Jr, Burger PC, et al. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg. 1991;74(3):441–446.
Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-Brain Tumor Treatment Group. Lancet. 1995;345:1008–1012.
Menei P, Boisdron-Celle M, Croue A, Guy G, Benoit JP. Effect of stereotactic implantation of biodegradable 5-flurouracil-loaded microspheres in healthy and C6 glioma-bearing rats. Neurosurg. 1996;39:117–124.
Bellinzona M, Roser F, Matthies C, Samii M, Saini M. Biopolymer mediated suramin chemotherapy in the treatment of experimental brain tumors. Acta Oncol. 2004;43(3):259–263.
Hsu W, Lesniak MS, Tyler B, Brem H. Local delivery of interleukin-2 and adriamycin is synergistic in the treatment of experimental malignant glioma. J Neurooncol. 2005;74:135–140.
Chen W, He J, Olson JJ, Lu DR. Carboplatin-loaded PLGA microspheres for intracerebral implantation: in vivo characterization. Drug Deliv. 1997;4(4):301–3111.
Lesniak MS, Upadhyay U, Goodwin R, Tyler B, Brem H. Local delivery of doxorubicin for the treatment of malignant brain tumors in rats. Anticancer Res. 2005;28(6B):3825–3831.
Lu W, Wan J, Zhang Q, She Z, Jiang X. Aclarubicin-loaded cationic-albumin pegylated nanoparticle for glioma chemotherapy in rats. Int J Cancer. 2007;120:420–431.
Walter KA, Cahen MA, Gur A, Tyler B, Hilton J, Colvin OM, et al. Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. Cancer Res. 1994;54:2207–2212.
Prados MD, Schold SC, Spence AM, Berger MS, Mcallister LD, Mehta MP, et al. Phase II study of paclitaxel in patients with recurrent malignant glioma. J Clin Oncol. 1996;14:2316–2321.
Chamberlain MC, Kormanik P. Salvage chemotherapy with taxol for recurrent anaplastic astrocytoma. J Neurooncol. 1999;43:269–276.
Chang SM, Kuhn JG, Robins HI, Schol SC Jr, Spence AM, Berger MS, et al. A phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants: a North American Brain Tumor Consortium report. Cancer. 2001;91:417–422.
Glantz MJ, Choy H, Kearns CM, Mills PC, Wahlberg LU, Zuhowski EG, et al. Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors. J Natl Cancer Inst (Bethesda). 1995;87:1077–1081.
Li KW, Dang W, Tyler BM, Troiano G, Tihan T, Brem H, et al. Polilactofate microspheres for paclitaxel delivery to central nervous system malignancies. Clin Cancer Res. 2003;9:3441–3447.
Fung LK, Ewend MG, Sills A, Sipos EP, Thompson R, Watts M, et al. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. Cancer Res. 1998;58:672–684.
Vogelhuber W, Sprub T, Bernhardt G, Buschauer A, Gopferich A. Efficacy of BCNU and paclitaxel loaded subcutaneous implants in the interstitial chemotherapy of U-87 MG human glioblastoma xenografts. Int J Pharm. 2002;238:111–121.
Wang J, Ng CW, Win KY, Shoemakers P, Lee TKY, Feng SS, et al. Release of paclitaxel from polylactide-co-glycolide (PLGA) microparticles and discs under irradiation. J Microencapsul. 2003;20(3):317–327.
Ranganath SH, Wang CH. Biodegradable microfiber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma. Biomaterials. 2008;29:2996–3003.
Xie J, Marijnissen JCM, Wang CH. Microparticles developed by electrohydrodynamic atomization for the local delivery of anticancer drug to treat C6 glioma in vitro. Biomaterials. 2006;27:3321–3332.
Elkharraz K, Faisant N, Guse C, Siepmann F, Arica-Yegin B, Oger JM, et al. Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: Preparation and physicochemical characterization. Int J Pharm. 2006;314:127–136.
Xie J, Wang CH. Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel. Pharma Res. 2005;22(12):2079–2090.
Geurin C, Olivi A, Weingart JD, Lawson HC, Brem H. Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers. Invest New Drugs. 2004;22:27–73.
Joki T, Machluf M, Atala A, Zhu J, Seyfried NT, Dunn IF, et al. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat Biotechnol. 2001;19:35–39.
Fantazzini P, Garavaglia C, Gomez S, Toffanin R, Vittur F. Chondrocyte-alginate bioconstructs: an nuclear magnetic resonance relaxation study. J Biomed Mater Res A. 2007;83A(2):345–353.
Rokstad AM, Strand B, Rian K, Steinkjer B, Kulseng B, Skjak-Braek G, et al. Evaluation of different types of alginate microcapsules as bioreactors for producing endostatin. Cell Transplant. 2003;12:351–364.
Chen H, Ouyang W, Jones M, Metz T, Martoni C, Haque T, et al. Preparation and characterization of novel polymeric microcapsules for live cell encapsulation and therapy. Cell Biochem Biophys. 2007;47:159–167.
Xie J, Wang CH. Electrospray in the dripping mode for cell microencapsulation. J Colloid Interf Sci. 2007;312:247–255.
Soares JP, Santos JE, Chierice GO, Cavalheiro ETG. Thermal behavior of alginic acid and its sodium salt. Ecletica Quimica. 2004;29(2):53–56.
Xie J, Lim LK, Phua Y, Hua J, Wang CH. Electrohydrodynamic atomization for biodegradable polymeric particle production. J Colloid Interf Sci. 2006;302:103–113.
Dubernet C. Thermoanalysis of microspheres. Thermochimica Acta. 1995;248:259–269.
Donth EJ. Relaxation and thermodynamics in polymers. Glass transition. Berlin: Akademie Verlag; 1992.
Freiberg S, Zhu XX. Polymer microspheres for controlled drug release. Int J Pharm. 2004;282:1–18.
Boontheekul T, Kong HJ, Mooney DJ. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials. 2005;26:2455–2465.
Liu J, Meisner D, Kwong E, Wu XY, Johnston MR. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres. Biomaterials. 2007;28:3236–3244.
ACKNOWLEDGEMENTS
The authors acknowledge the Biomedical Research Council (BMRC), A*STAR and the National University of Singapore for providing support under the grant numbers BMRC/07/1/21/19/508 and R279-000-257-731, respectively. The authors thank Alvin Yang, Ying Ying Chan, Jinghan Huang and Hui Yian Tan for technical assistance in the preparation of this manuscript and Dr. Yilong Fu for his assistance in the animal experiments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ranganath, S.H., Kee, I., Krantz, W.B. et al. Hydrogel Matrix Entrapping PLGA-Paclitaxel Microspheres: Drug Delivery with Near Zero-Order Release and Implantability Advantages for Malignant Brain Tumour Chemotherapy. Pharm Res 26, 2101–2114 (2009). https://doi.org/10.1007/s11095-009-9922-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-009-9922-2